Brunner Maximilian, Jendrusch Theresa, Golcher Henriette, Weber Klaus, Denz Axel, Weber Georg F, Grützmann Robert, Krautz Christian
Department of General and Visceral Surgery, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Krankenhausstraße 12, 91054 Erlangen, Germany.
J Clin Med. 2025 Jul 21;14(14):5167. doi: 10.3390/jcm14145167.
: The aim of the present study was to investigate the impact of postoperative morbidity on mid-term quality of life and patient-related outcome (PRO) parameters after colorectal surgery for colorectal carcinoma. : Quality of life and perioperative data were prospectively collected from 99 adult patients treated for colorectal carcinoma-56 patients with colonic carcinoma and 43 with rectal carcinoma, all of whom underwent R0 colorectal resection, at the University Hospital Erlangen between 2018 and 2021. Quality of life data (EQL C29 and C30) were assessed before the start of treatment and one year after. Patients were grouped based on the presence or absence of postoperative morbidity, and their quality of life was compared between the two groups. : In the colonic carcinoma cohort, global quality of life and emotional functioning showed significant improvement from pre-treatment to the one-year follow-up (63 vs. 72, = 0.012 and 63 vs. 76, = 0.009, respectively). Among the symptom scales, five items improved, while two worsened. Patients who experienced postoperative morbidity (32% in the colonic carcinoma group) did not exhibit worse outcomes in functioning or symptom scales compared to those without morbidity (4 items improved and 1 worsened in the morbidity group vs. 3 improved and 1 worsened in the no-morbidity group). The rectal carcinoma cohort demonstrated a decline in quality of life from pre-treatment to the one-year follow-up. Two functioning scales worsened significantly (physical function: 89 vs. 83, < 0.001; role function: 81 vs. 68, = 0.009), and twelve symptom scales showed deterioration, with only two symptom scales improving. Postoperative morbidity (33% in the rectal carcinoma group) did not result in more pronounced impairments compared to those without morbidity. The morbidity group experienced 2 worsened and 0 improved items, while the no-morbidity group had 10 worsened and 1 improved item. : Postoperative morbidity was not significantly associated with a worse quality of life at one-year follow-up after treatment of colorectal carcinomas, including colorectal resections, compared to patients who did not develop postoperative morbidity.
本研究的目的是调查结直肠癌结直肠手术后术后发病情况对中期生活质量和患者相关结局(PRO)参数的影响。前瞻性收集了2018年至2021年在埃尔朗根大学医院接受治疗的99例成年结直肠癌患者的生活质量和围手术期数据,其中56例为结肠癌患者,43例为直肠癌患者,所有患者均接受了R0结直肠切除术。在治疗开始前和治疗一年后评估生活质量数据(EQL C29和C30)。根据术后是否发病对患者进行分组,并比较两组患者的生活质量。在结肠癌队列中,从治疗前到一年随访,总体生活质量和情感功能有显著改善(分别为63对72,P = 0.012;63对76,P = 0.009)。在症状量表中,有5项改善,2项恶化。与未发病患者相比,发生术后发病的患者(结肠癌组为32%)在功能或症状量表上并未表现出更差的结局(发病组4项改善,1项恶化;未发病组3项改善,1项恶化)。直肠癌队列显示从治疗前到一年随访生活质量有所下降。两个功能量表显著恶化(身体功能:89对83,P < 0.001;角色功能:81对68,P = 0.009),12个症状量表显示恶化,只有2个症状量表有所改善。术后发病(直肠癌组为33%)与未发病患者相比并未导致更明显的损害。发病组有2项恶化,0项改善;未发病组有10项恶化,1项改善。与未发生术后发病的患者相比,结直肠癌(包括结直肠切除术)治疗后一年随访时,术后发病与较差的生活质量无显著相关性。